{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:35:27Z","timestamp":1787070927581,"version":"build-2736575974"},"reference-count":75,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"Suppl 2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,1]]},"abstract":"<jats:title>ABSTRACTS<\/jats:title>\n                  <jats:p>Gallbladder cancer (GBC) is one of the quiet prevalent and aggressive biliary tract malignant neoplasms distinguished by significant cellular heterogeneity, metastatic activity, and a poor prognosis, with varied frequency worldwide. Most cases are detected incidentally while routine screening imaging or pathological investigation of cholecystectomy tissues and usually present with advanced disease. The surgical resection is usually done in the initial clinical stage having limited spread. Despite the surgical therapy, the death rate is significant. Furthermore, the molecular mechanisms affecting the clinical course of inflammatory gallbladder to carcinogenesis remain poorly understood. There is an impending need for developing diagnostic biomarkers and targeted approaches for GBC. The newer molecular platform, such as next-generation sequencing (NGS), such as RNA-sequencing (RNAseq), single-cell sequencing, and microarray technology, has revolutionized the field of genomics, opened a new perspective in defining genetic and epigenetic characteristics identifying molecules as possible therapeutic targets. Therefore, in this review, we would analyze transcriptomic and epigenomics profiles of GBC using already published high-throughput sequencing-based studies published between 2010 and 2023. The review would also analyze the possible impact of the technological advancement on the patient management strategy and overall survival. This may also help identify target genes and pathways linked to GBC, which may help establish molecular biomarkers, for early GBC diagnosis, personalized therapy, and management.<\/jats:p>","DOI":"10.4103\/jcrt.jcrt_1823_23","type":"journal-article","created":{"date-parts":[[2024,2,21]],"date-time":"2024-02-21T03:01:24Z","timestamp":1708484484000},"page":"S499-S507","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["A Comprehensive narrative review of transcriptomics and epigenomics of gallbladder cancer"],"prefix":"10.4103","volume":"19","author":[{"given":"Pranay","family":"Tanwar","sequence":"first","affiliation":[{"name":"Laboratory Oncology Unit, Dr BRA-IRCH, All India Institute of Medical Sciences, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shilpi","family":"Minocha","sequence":"additional","affiliation":[{"name":"Kusuma School of Biological Sciences, Indian Institute of Technology Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ishaan","family":"Gupta","sequence":"additional","affiliation":[{"name":"Department of Biochemical Engineering and Biotechnology, Indian Institute of Technology Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,2,21]]},"reference":[{"key":"R1-20241021","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21590","article-title":"Cancer statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Cancer J Clin"},{"key":"R2-20241021","doi-asserted-by":"crossref","first-page":"35","DOI":"10.21037\/cco.2019.07.03","article-title":"Management of gallbladder cancer in India","volume":"8","author":"Acharya","year":"2019","journal-title":"Chin Clin Oncol"},{"key":"R3-20241021","doi-asserted-by":"crossref","first-page":"379","DOI":"10.2147\/CMAR.S157156","article-title":"Biliary tract cancer: Current challenges and future prospects","volume":"11","author":"Ghidini","year":"2019","journal-title":"Cancer Manag Res"},{"key":"R4-20241021","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/j.hpb.2019.03.370","article-title":"Evolution of surgical management of gallbladder carcinoma and impact on outcome: Results from two decades at a single-institution","volume":"21","author":"Creasy","year":"2019","journal-title":"HPB (Oxford)"},{"key":"R5-20241021","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics, 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"R7-20241021","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/ijc.21683","article-title":"Gallbladder cancer worldwide: Geographical distribution and risk factors","volume":"118","author":"Randi","year":"2006","journal-title":"Int J Cancer"},{"key":"R8-20241021","first-page":"221","article-title":"Gallbladder cancer","volume":"3","author":"Raki\u0107","year":"2014","journal-title":"Hepatobiliary Surg Nutr"},{"key":"R9-20241021","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ejca.2016.10.012","article-title":"Healthy dietary patterns and incidence of biliary tract and gallbladder cancer in a prospective study of women and men","volume":"70","author":"Larsson","year":"2017","journal-title":"Eur J Cancer"},{"key":"R10-20241021","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/CEJ.0000000000000260","article-title":"Reproductive factors and gallbladder\/bile duct cancer: A population-based cohort study in Japan","volume":"26","author":"Makiuchi","year":"2017","journal-title":"Eur J Cancer Prev"},{"key":"R11-20241021","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1634\/theoncologist.2009-0302","article-title":"Current management of gallbladder carcinoma","volume":"15","author":"Zhu","year":"2010","journal-title":"Oncologist"},{"key":"R12-20241021","doi-asserted-by":"crossref","first-page":"349","DOI":"10.3322\/canjclin.51.6.349","article-title":"Epidemiology and molecular pathology of gallbladder cancer","volume":"51","author":"Lazcano-Ponce","year":"2001","journal-title":"CA Cancer J Clin"},{"key":"R13-20241021","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1002\/1097-0142(19920915)70:6<1493::AID-CNCR2820700608>3.0.CO;2-U","article-title":"Carcinoma of the gallbladder. Histologic types, stage of disease, grade, and survival rates","volume":"70","author":"Henson","year":"1992","journal-title":"Cancer"},{"key":"R14-20241021","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s10396-016-0742-9","article-title":"The role of endoscopic ultrasound in the diagnosis of gallbladder diseases","volume":"44","author":"Chantarojanasiri","year":"2017","journal-title":"J Med Ultrason (2001)"},{"key":"R15-20241021","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1002\/jmri.24810","article-title":"MRI of cholangiocarcinoma","volume":"42","author":"Jhaveri","year":"2015","journal-title":"J Magn Reson Imaging"},{"key":"R16-20241021","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1148\/radiol.2018171187","article-title":"Imaging diagnosis of intrahepatic and perihilar cholangiocarcinoma: Recent advances and challenges","volume":"288","author":"Joo","year":"2018","journal-title":"Radiology"},{"key":"R17-20241021","doi-asserted-by":"crossref","first-page":"498","DOI":"10.21037\/hbsn-20-846","article-title":"Modified FOLFIRINOX for unresectable locally advanced or metastatic gallbladder cancer, a comparison with GEMOX regimen","volume":"10","author":"Cui","year":"2021","journal-title":"Hepatobiliary Surg Nutr"},{"key":"R18-20241021","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.suc.2018.12.008","article-title":"Gallbladder cancer: Diagnosis, surgical management, and adjuvant therapies","volume":"99","author":"Hickman","year":"2019","journal-title":"Surg Clin North Am"},{"key":"R19-20241021","doi-asserted-by":"crossref","first-page":"37","DOI":"10.21037\/cco.2019.07.01","article-title":"Evaluation and management of incidental gallbladder cancer","volume":"8","author":"Zaidi","year":"2019","journal-title":"Chin Clin Oncol"},{"key":"R20-20241021","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/s41392-020-00324-2","article-title":"Overview of current targeted therapy in gallbladder cancer","volume":"5","author":"Song","year":"2020","journal-title":"Signal Transduct Target Ther"},{"key":"R21-20241021","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1080\/13543784.2021.1928636","article-title":"Targeted therapies for gallbladder cancer: An overview of agents in preclinical and clinical development","volume":"30","author":"De Lorenzo","year":"2021","journal-title":"Expert OpinInvestig Drugs"},{"key":"R22-20241021","doi-asserted-by":"crossref","first-page":"4503","DOI":"10.1200\/jco.2009.27.15_suppl.4503","article-title":"Gemcitabine with or without cisplatin in patients (pts) with advanced or metastatic biliary tract cancer (ABC): Results of a multicenter, randomized phase III trial (the UK ABC-02 trial)","volume":"27","author":"Valle","year":"2009","journal-title":"J Clin Oncol"},{"key":"R23-20241021","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/cam4.2679","article-title":"Treatment of advanced gallbladder cancer: A SEER-based study","volume":"9","author":"Mao","year":"2020","journal-title":"Cancer Med"},{"issue":"Suppl 1","key":"R24-20241021","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/hep.31325","article-title":"Surgical treatments of hepatobiliary cancers","volume":"73","author":"Gunasekaran","year":"2021","journal-title":"Hepatology"},{"key":"R25-20241021","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1136\/gutjnl-2018-316039","article-title":"Genomic ERBB2\/ERBB3 mutations promote PD-L1-mediated immune escape in gallbladder cancer: A whole-exome sequencing analysis","volume":"68","author":"Li","year":"2019","journal-title":"Gut"},{"key":"R26-20241021","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1038\/ng.3030","article-title":"Whole-exome and targeted gene sequencing of gallbladder carcinoma identifies recurrent mutations in the ErbB pathway","volume":"46","author":"Li","year":"2014","journal-title":"Nat Genet"},{"key":"R27-20241021","doi-asserted-by":"crossref","first-page":"6395","DOI":"10.1007\/s11033-022-07448-4","article-title":"Unravelling of the comparative transcriptomic profile of gallbladder cancer using mRNA sequencing","volume":"49","author":"Dixit","year":"2022","journal-title":"Mol Biol Rep"},{"key":"R28-20241021","doi-asserted-by":"crossref","first-page":"e678","DOI":"10.1002\/ctm2.678","article-title":"Patient-derived organoids for personalized gallbladder cancer modelling and drug screening","volume":"12","author":"Yuan","year":"2022","journal-title":"Clin Transl Med"},{"key":"R29-20241021","doi-asserted-by":"crossref","first-page":"4225","DOI":"10.1038\/s41467-020-17880-4","article-title":"Integrated genomic analysis reveals mutated ELF3 as a potential gallbladder cancer vaccine candidate","volume":"11","author":"Pandey","year":"2020","journal-title":"Nat Commun"},{"key":"R30-20241021","doi-asserted-by":"crossref","first-page":"277","DOI":"10.32471\/exp-oncology.2312-8852.vol-42-no-4.15476","article-title":"Microarray based gene expression profiling of advanced gall bladder cancer","volume":"42","author":"Kumar","year":"2020","journal-title":"Exp Oncol"},{"key":"R31-20241021","first-page":"25","article-title":"A transcriptome profile in gallbladder cancer based on annotation analysis of microarray studies","volume":"23","author":"Ge","year":"2021","journal-title":"Mol Med Rep"},{"key":"R32-20241021","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1159\/000132570","article-title":"Gene expression profiles in gallbladder cancer: The close genetic similarity seen for early and advanced gallbladder cancers may explain the poor prognosis","volume":"29","author":"Kim","year":"2008","journal-title":"Tumour Biol"},{"key":"R33-20241021","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.cell.2015.05.002","article-title":"Highly parallel genome-wide expression profiling of individual cells using nanoliter droplets","volume":"161","author":"Macosko","year":"2015","journal-title":"Cell"},{"key":"R34-20241021","doi-asserted-by":"crossref","first-page":"104319","DOI":"10.1016\/j.ebiom.2022.104319","article-title":"Single-cell RNA sequencing highlights the functional role of human endogenous retroviruses in gallbladder cancer","volume":"85","author":"Wang","year":"2022","journal-title":"eBioMedicine"},{"key":"R35-20241021","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/j.jhep.2021.06.023","article-title":"Single-cell RNA-sequencing atlas reveals an MDK-dependent immunosuppressive environment in ErbB pathway-mutated gallbladder cancer","volume":"75","author":"Zhang","year":"2021","journal-title":"J Hepatol"},{"key":"R36-20241021","doi-asserted-by":"crossref","first-page":"e462","DOI":"10.1002\/ctm2.462","article-title":"Diversity and intratumoral heterogeneity in human gallbladder cancer progression revealed by single-cell RNA sequencing","volume":"11","author":"Chen","year":"2021","journal-title":"Clin Transl Med"},{"key":"R37-20241021","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nrg.2015.10","article-title":"Unique features of long non-coding RNA biogenesis and function","volume":"17","author":"Quinn","year":"2016","journal-title":"Nat Rev Genet"},{"key":"R38-20241021","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.cell.2018.01.011","article-title":"Functional classification and experimental dissection of long noncoding RNAs","volume":"172","author":"Kopp","year":"2018","journal-title":"Cell"},{"key":"R39-20241021","doi-asserted-by":"crossref","first-page":"6134","DOI":"10.1080\/21655979.2021.1972780","article-title":"Exploration of differentially-expressed exosomal mRNAs, lncRNAs and circRNAs from serum samples of gallbladder cancer and xantho-granulomatous cholecystitis patients","volume":"12","author":"Ren","year":"2021","journal-title":"Bioengineered"},{"key":"R40-20241021","doi-asserted-by":"crossref","first-page":"154320","DOI":"10.1016\/j.prp.2023.154320","article-title":"Circulating microRNAs in gallbladder cancer: Is serum assay of diagnostic value?","volume":"242","author":"Srivastava","year":"2023","journal-title":"Pathol Res Pract"},{"key":"R41-20241021","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s11658-022-00398-6","article-title":"tRF-3013b inhibits gallbladder cancer proliferation by targeting TPRG1L","volume":"27","author":"Zou","year":"2022","journal-title":"Cell Mol Biol Lett"},{"key":"R42-20241021","first-page":"1770643","article-title":"MRNA profiling involved in triggering of STAT1 with regulatory involvement of IRF7, PTPRF, and miR-145p in patients suffering from gall bladder carcinoma","author":"Zhao","year":"2022","journal-title":"J Healthc Eng 2022"},{"key":"R43-20241021","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1080\/15384101.2021.1874694","article-title":"miR-365 inhibits the progression of gallbladder carcinoma and predicts the prognosis of Gallbladder carcinoma patients","volume":"20","author":"Jiang","journal-title":"Cell Cycle"},{"key":"R44-20241021","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s00535-019-01627-0","article-title":"High-throughput screening identified miR-7-2-3p and miR-29c-3p as metastasis suppressors in gallbladder carcinoma","volume":"55","author":"Lu","year":"2020","journal-title":"J Gastroenterol"},{"key":"R45-20241021","doi-asserted-by":"crossref","first-page":"BSR20194509","DOI":"10.1042\/BSR20194509","article-title":"Overexpression of microRNA-205-5p exerts suppressive effects on stem cell drug resistance in gallbladder cancer by down-regulating PRKCE","volume":"40","author":"Zhang","year":"2020","journal-title":"Biosci Rep"},{"key":"R46-20241021","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/s41434-020-00187-w","article-title":"Silencing of long non-coding RNA FOXD2-AS1 inhibits the progression of gallbladder cancer by mediating methylation of MLH1","volume":"28","author":"Gao","year":"2021","journal-title":"Gene Ther"},{"key":"R47-20241021","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/s12943-019-1098-8","article-title":"Circular RNA circERBB2 promotes gallbladder cancer progression by regulating PA2G4-dependent rDNA transcription","volume":"18","author":"Huang","year":"2019","journal-title":"Mol Cancer"},{"key":"R48-20241021","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s12943-019-1078-z","article-title":"Circular RNA FOXP1 promotes tumor progression and Warburg effect in gallbladder cancer by regulating PKLR expression","volume":"18","author":"Wang","year":"2019","journal-title":"Mol Cancer"},{"key":"R49-20241021","doi-asserted-by":"crossref","first-page":"4796","DOI":"10.1038\/s41598-019-40857-3","article-title":"Profiling of gallbladder carcinoma reveals distinct miRNA profiles and activation of STAT1 by the tumor suppressive miRNA-145-5p","volume":"9","author":"Goeppert","year":"2019","journal-title":"Sci Rep"},{"key":"R50-20241021","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.3748\/wjg.v22.i5.1787","article-title":"MicroRNA aberrations: An emerging field for gallbladder cancer management","volume":"22","author":"Chandra","year":"2016","journal-title":"World J Gastroenterol"},{"key":"R51-20241021","doi-asserted-by":"crossref","first-page":"6985","DOI":"10.1007\/s13277-015-3412-4","article-title":"MicroRNA signatures in total peripheral blood of gallbladder cancer patients","volume":"36","author":"Li","year":"2015","journal-title":"Tumour Biol"},{"key":"R52-20241021","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1097\/CM9.0000000000001075","article-title":"Topoisomerase II alpha promotes gallbladder cancer proliferation and metastasis through activating phosphatidylinositol 3-kinase\/protein kinase B\/mammalian target of rapamycin signaling pathway","volume":"133","author":"Lyu","year":"2020","journal-title":"Chin Med J (Engl)"},{"key":"R53-20241021","doi-asserted-by":"crossref","first-page":"49897","DOI":"10.18632\/oncotarget.18180","article-title":"Ring finger protein 125, as a potential highly aggressive and unfavorable prognostic biomarker, promotes the invasion and metastasis of human gallbladder cancers via activating the TGF- ?1-SMAD3-ID1 signaling pathway","volume":"8","author":"Liu","year":"2017","journal-title":"Oncotarget"},{"key":"R54-20241021","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1097\/PAI.0000000000000307","article-title":"Cytokeratin 17 expression is associated with poor prognosis in gallbladder adenocarcinoma","volume":"25","author":"Kim","year":"2017","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"R55-20241021","doi-asserted-by":"crossref","first-page":"72833","DOI":"10.18632\/oncotarget.12023","article-title":"Long non-coding RNA CRNDE promotes gallbladder carcinoma carcinogenesis and as a scaffold of DMBT1 and C-IAP1 complexes to activating PI3K-AKT pathway","volume":"7","author":"Shen","year":"2016","journal-title":"Oncotarget"},{"key":"R56-20241021","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.4103\/0973-1482.137977","article-title":"Prognostic significance of metastasis associated in colon cancer 1 (MACC1) expression in patients with gallbladder cancer","volume":"10","author":"Chen","year":"2014","journal-title":"J Cancer Res Ther"},{"key":"R57-20241021","doi-asserted-by":"crossref","first-page":"e36275","DOI":"10.1371\/journal.pone.0036275","article-title":"Clinical potential of DNA methylation in gastric cancer: A meta-analysis","volume":"7","author":"Sapari","year":"2012","journal-title":"PLoS One"},{"key":"R58-20241021","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1101\/gr.101907.109","article-title":"Dynamic changes in the human methylome during differentiation","volume":"20","author":"Laurent","year":"2010","journal-title":"Genome Res"},{"key":"R59-20241021","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/nrc1045","article-title":"The power and the promise of DNA methylation markers","volume":"3","author":"Laird","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"R60-20241021","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1146\/annurev-pathol-011110-130235","article-title":"Molecular genetics of colorectal cancer","volume":"6","author":"Fearon","year":"2011","journal-title":"Annu Rev Pathol"},{"key":"R61-20241021","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.cell.2007.01.029","article-title":"The epigenomics of cancer","volume":"128","author":"Jones","year":"2007","journal-title":"Cell"},{"key":"R62-20241021","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.devcel.2010.10.005","article-title":"Aberrant epigenetic landscape in cancer: How cellular identity goes awry","volume":"19","author":"Berdasco","year":"2010","journal-title":"Dev Cell"},{"key":"R63-20241021","doi-asserted-by":"crossref","first-page":"14687","DOI":"10.1007\/s13277-016-5355-9","article-title":"Global methylation profiling to identify epigenetic signature of gallbladder cancer and gallstone disease","volume":"37","author":"Sharma","year":"2016","journal-title":"Tumour Biol"},{"key":"R64-20241021","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.gene.2015.10.004","article-title":"Epigenetic profiling of gallbladder cancer and gall stone diseases: Evaluation of role of tumour associated genes","volume":"576","author":"Singh","year":"2016","journal-title":"Gene"},{"key":"R65-20241021","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.3892\/ol.2014.1838","article-title":"Analysis of DNA methylation patterns associated with the gastric cancer genome","volume":"7","author":"Cheng","year":"2014","journal-title":"Oncol Lett"},{"key":"R66-20241021","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1186\/s13046-021-02186-0","article-title":"Epigenetic activation of the elongator complex sensitizes gallbladder cancer to gemcitabine therapy","volume":"40","author":"Xu","year":"2021","journal-title":"J Exp Clin Cancer Res"},{"key":"R67-20241021","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1002\/hep.31585","article-title":"Epigenome-wide analysis of methylation changes in the sequence of gallstone disease, dysplasia, and gallbladder cancer","volume":"73","author":"Br\u00e4gelmann","year":"2021","journal-title":"Hepatology"},{"key":"R68-20241021","doi-asserted-by":"crossref","first-page":"e0206643","DOI":"10.1371\/journal.pone.0206643","article-title":"Loss of BAP1 expression is associated with genetic mutation and can predict outcomes in gallbladder cancer","volume":"13","author":"Hirosawa","year":"2018","journal-title":"PLoS One"},{"key":"R69-20241021","doi-asserted-by":"crossref","first-page":"233","DOI":"10.2217\/fon.14.165","article-title":"Global and gene-specific DNA methylation pattern discriminates cholecystitis from gallbladder cancer patients in Chile","volume":"11","author":"Kagohara","year":"2015","journal-title":"Future Oncol"},{"key":"R70-20241021","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/mc.20457","article-title":"Promoter methylation profile in preneoplastic and neoplastic gallbladder lesions","volume":"48","author":"Garc\u00eda","year":"2009","journal-title":"Mol Carcinog"},{"key":"R71-20241021","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S1016-8478(23)07352-1","article-title":"Hypermethylation of the Ras association domain family 1A (RASSF1A) gene in gallbladder cancer","volume":"24","author":"Kee","year":"2007","journal-title":"Mol Cells"},{"key":"R72-20241021","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s00535-005-1752-3","article-title":"Promoter methylation profile in gallbladder cancer","volume":"41","author":"Roa","year":"2006","journal-title":"J Gastroenterol"},{"key":"R73-20241021","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1111\/j.1349-7006.2006.00320.x","article-title":"Hypomethylation of the protein gene product 9.5 promoter region in gallbladder cancer and its relationship with clinicopathological features","volume":"97","author":"Lee","year":"2006","journal-title":"Cancer Sci"},{"key":"R74-20241021","doi-asserted-by":"crossref","first-page":"6126","DOI":"10.1158\/1078-0432.CCR-04-0579","article-title":"Aberrant promoter hypermethylation of multiple genes in gallbladder carcinoma and chronic cholecystitis","volume":"10","author":"Takahashi","year":"2004","journal-title":"Clin Cancer Res"},{"key":"R75-20241021","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1245\/ASO.2003.02.014","article-title":"Progression of gene hypermethylation in gallstone disease leading to gallbladder cancer","volume":"10","author":"House","year":"2003","journal-title":"Ann Surg Oncol"},{"key":"R76-20241021","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/s41392-020-00324-2","article-title":"Overview of current targeted therapy in gallbladder cancer","volume":"5","author":"Xiaoling","year":"2020","journal-title":"Signal Transduct Target Ther"}],"container-title":["Journal of Cancer Research and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.jcrt_1823_23","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:39:03Z","timestamp":1787067543000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.jcrt_1823_23"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":75,"journal-issue":{"issue":"Suppl 2","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.4103\/jcrt.jcrt_1823_23","relation":{},"ISSN":["0973-1482","1998-4138"],"issn-type":[{"value":"0973-1482","type":"print"},{"value":"1998-4138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"2023-08-14","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-09-25","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}